OUTCOMES OF VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH RHEUMATIC DISEASES IN LATVIA

Medicine and Dentistry

• Side Effect 100%
• Severe Acute Respiratory Syndrome 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 50%
• Rheumatoid Arthritis 50%
• Inflammatory Arthritis 50%
• Comorbidity 50%
• Retrospective Study 25%
• Disease Activity 25%
• Disease-Modifying Antirheumatic Drug 25%
• Antirheumatic Agent 25%
• Immunosuppressive Drug 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Severe Acute Respiratory Syndrome 100%
• Side Effect 100%
• SARS Coronavirus 50%
• Rheumatoid Arthritis 50%
• Comorbidity 50%
• Inflammatory Arthritis 50%
• Retrospective Study 25%
• Remission 25%
• Antirheumatic Agent 25%
• Disease Activity 25%
• Immunosuppressive Agent 25%

Immunology and Microbiology

• Inflammatory Arthritis 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Severe Acute Respiratory Syndrome 100%
• Comorbidity 100%
• Immunosuppressive Drug 50%